Current status of viral expression systems in plants and perspectives for oral vaccines development

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Plant Molecular Biology

• Publication date

  2015-01-06

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s11103-014-0279-5PMID 25560432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transgenic plants: a 5-year update on oral antipathogen vaccine development

  2014cited by this paper
• Plant viral vectors for delivery by Agrobacterium.

  2014cited by this paper
• M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.

  2014cited by this paper
• Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana

  2014cited by this paper
• Design and construction of an in-plant activation cassette for transgene expression and recombinant protein production in plants

  2014cited by this paper
• A Plant-Produced Antigen Elicits Potent Immune Responses against West Nile Virus in Mice

  2014cited by this paper
• Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults.

  2014cited by this paper
• A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.

  2014cited by this paper
• Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines

  2014cited by this paper
• Recent progress in adjuvant discovery for peptide-based subunit vaccines

  2014cited by this paper
• Immunological aspects of using plant cells as delivery vehicles for oral vaccines

  2014influential reference
• Plant Viral Vectors

  2014cited by this paper
• The potential of Physcomitrella patens as a platform for the production of plant-based vaccines

  2014cited by this paper
• Challenges in mucosal vaccines for the control of infectious diseases.

  2014cited by this paper
• Modern Subunit Vaccines: Development, Components, and Research Opportunities

  2013cited by this paper
• Recombinant therapeutic protein vaccines.

  2013cited by this paper
• Mutation of a Short Variable Region in HCpro Protein of Potato virus A Affects Interactions with a Microtubule-Associated Protein and Induces Necrotic Responses in Tobacco.

  2013cited by this paper
• Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

  2013cited by this paper
• Geminiviruses: masters at redirecting and reprogramming plant processes

  2013cited by this paper
• In Plant Activation: An Inducible, Hyperexpression Platform for Recombinant Protein Production in Plants[W][OPEN]

  2013cited by this paper
• Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen.

  2013cited by this paper
• Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods.

  2012cited by this paper
• Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce.

  2012cited by this paper
• Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins.

  2012cited by this paper
• Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein

  2012cited by this paper
• Is an oral plant-based vaccine against hepatitis B virus possible?

  2012cited by this paper
• Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants

  2012cited by this paper
• Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond

  2011cited by this paper
• Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.

  2011cited by this paper
• A plant‐based system for rapid production of influenza vaccine antigens

  2011cited by this paper
• Expression of a recombinant chimeric protein of hepatitis A virus VP1-Fc using a replicating vector based on Beet curly top virus in tobacco leaves and its immunogenicity in mice

  2011cited by this paper
• High-level recombinant protein expression in transgenic plants by using a double-inducible viral vector

  2011cited by this paper
• Plant-Derived Antigens as Mucosal Vaccines

  2011cited by this paper
• Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants

  2011cited by this paper
• A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions

  2011cited by this paper
• Non-toxic derivatives of LT as potent adjuvants.

  2011cited by this paper
• Co-expression of multiple target proteins in plants from a tobacco mosaic virus vector using a combination of homologous and heterologous subgenomic promoters

  2011cited by this paper
• Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza

  2010cited by this paper
• High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector.

  2010cited by this paper
• Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases.

  2010cited by this paper
• High‐level rapid production of full‐size monoclonal antibodies in plants by a single‐vector DNA replicon system

  2010cited by this paper
• Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system.

  2009cited by this paper
• Plant-Based Oral Vaccines: Results of Human Trials

  2009cited by this paper
• Cowpea mosaic virus-based systems for the expression of antigens and antibodies in plants.

  2009cited by this paper
• A DNA replicon system for rapid high‐level production of virus‐like particles in plants

  2009cited by this paper
• Expression of HIV-1 antigens in plants as potential subunit vaccines

  2008cited by this paper
• A plant‐produced influenza subunit vaccine protects ferrets against virus challenge

  2008cited by this paper
• An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles.

  2008cited by this paper
• Geminivirus strain demarcation and nomenclature

  2008cited by this paper
• Transient expression of HPV16 E7 peptide (aa 44-60) and HPV16 L2 peptide (aa 108-120) on chimeric potyvirus-like particles using Potato virus X-based vector.

  2008cited by this paper
• High‐yield rapid production of hepatitis B surface antigen in plant leaf by a viral expression system

  2008cited by this paper
• Translational control of recombinant human acetylcholinesterase accumulation in plants

  2007cited by this paper
• TRBO: A High-Efficiency Tobacco Mosaic Virus RNA-Based Overexpression Vector1[C][OA]

  2007cited by this paper
• Anti-cancer activity of plant-produced HPV16 E7 vaccine.

  2007cited by this paper
• Production of dengue 2 envelope domain III in plant using TMV-based vector system.

  2007cited by this paper
• Improved expression of recombinant GFP using a replicating vector based on Beet curly top virus in leaf-disks and infiltrated Nicotiana benthamiana leaves

  2007cited by this paper
• Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine.

  2007cited by this paper
• Virus-like particles—universal molecular toolboxes

  2007cited by this paper
• Viral vectors for the expression of proteins in plants.

  2007cited by this paper
• A launch vector for the production of vaccine antigens in plants

  2007cited by this paper
• Expression of multiple proteins using full-length and deleted versions of cowpea mosaic virus RNA-2.

  2007cited by this paper
• Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.

  2006cited by this paper
• The Tombusvirus-encoded P19: from irrelevance to elegance

  2006cited by this paper
• Virus-like particles production in green plants.

  2006cited by this paper
• Bean Yellow Dwarf Virus replicons for high-level transgene expression in transgenic plants and cell cultures.

  2006cited by this paper
• High-yield production of authentic human growth hormone using a plant virus-based expression system.

  2005cited by this paper
• Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses.

  2005cited by this paper
• Peptide-based candidate vaccine against respiratory syncytial virus.

  2005cited by this paper
• Systemic Agrobacterium tumefaciens–mediated transfection of viral replicons for efficient transient expression in plants

  2005cited by this paper
• Magnifection--a new platform for expressing recombinant vaccines in plants.

  2005cited by this paper
• Expression of multiple foreign epitopes presented as synthetic antigens on the surface of Potato virus X particles

  2005cited by this paper
• Development of cowpea mosaic virus-based vectors for the production of vaccines in plants

  2005cited by this paper
• Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana.

  2004cited by this paper
• Geminivirus DNA replication and cell cycle interactions.

  2004cited by this paper
• Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies.

  2004cited by this paper
• Expression of a vaccine protein in a plant cell line using a geminivirus-based replicon system.

  2004cited by this paper
• RNA silencing in plants

  2004cited by this paper
• Cowpea mosaic virus RNA-1 acts as an amplicon whose effects can be counteracted by a RNA-2-encoded suppressor of silencing.

  2004cited by this paper
• On risk and plant-based biopharmaceuticals.

  2004cited by this paper
• Geminivirus vectors for high-level expression of foreign proteins in plant cells.

  2003cited by this paper
• Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity.

  2003cited by this paper
• An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus.

  2003cited by this paper
• MicroRNAs in plants.

  2002cited by this paper
• Identification of Immunogenic Hot Spots within Plum Pox Potyvirus Capsid Protein for Efficient Antigen Presentation

  2002cited by this paper
• Chimeric Plant Virus Particles as Immunogens for Inducing Murine and Human Immune Responses against Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector.

  2001cited by this paper
• A novel strategy for the expression of foreign genes from plant virus vectors

  2001cited by this paper
• Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants.

  2000cited by this paper
• Geminiviruses: models for plant DNA replication, transcription, and cell cycle regulation.

  2000cited by this paper
• Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes.

  2000cited by this paper
• Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.

  1999cited by this paper
• Generation of maize cell lines containing autonomously replicating maize streak virus-based gene vectors

  1999cited by this paper
• Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants.

  1999cited by this paper
• Cowpea mosaic virus-based vaccines.

  1999cited by this paper
• Susceptibility to recombination rearrangements of a chimeric plum pox potyvirus genome after insertion of a foreign gene.

  1998cited by this paper
• Consistent gene silencing in transgenic plants expressing a replicating potato virus X RNA

  1997cited by this paper
• RNA-Mediated Virus Resistance: Role of Repeated Transgenes and Delineation of Targeted Regions.

  1996cited by this paper
• Assembly and movement of a plant virus carrying a green fluorescent protein overcoat.

  1996cited by this paper
• Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

  1996cited by this paper
• Oral immunization with a recombinant bacterial antigen produced in transgenic plants

  1995cited by this paper

• Plant Viral Vectors for Vaccine Development

  2026cites this paper
• Engineering Conditional Transgene Expression in Nicotiana benthamiana

  2025cites this paper
• The Impacts of Environmental Factors and Culture Conditions on the Transient Expression of Recombinant Protein in Nicotiana benthamiana Under Controlled Environments

  2025cites this paper
• Precise Therapy Using the Selective Endogenous Encapsidation for Cellular Delivery Vector System

  2024cites this paper
• Citrus sudden death-associated virus as a new expression vector for rapid in planta production of heterologous proteins, chimeric virions, and virus-like particles

  2022cites this paper
• Emerging trends of edible vaccine therapy for combating human diseases especially COVID‐19: Pros, cons, and future challenges

  2022cites this paper
• Plant viral vectors: an strategy for transient expression of recombinant proteins in plants

  2022cites this paper
• Carrot cells expressing the VP1 and VP2 poliovirus proteins effectively elicited mucosal immunity

  2022cites this paper
• An Extensive Review on the Development of Plant-Based Vaccines against SARS-Cov-2 and Respiratory Disorders Using Plant Biotechnology Platform

  2022cites this paper
• Sustainable Microalgae and Cyanobacteria Biotechnology

  2022cites this paper
• Design and assembly of plant-based COVID-19 candidate vaccines: reсent development and future prospects

  2022cites this paper
• COVID-19 Pandemic and Vaccines

  2021cites this paper
• Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species

  2021cites this paper
• Plant-made vaccines against parasites: bioinspired perspectives to fight against Chagas disease

  2021cites this paper
• Engineering Approaches in Plant Molecular Farming for Global Health

  2021cites this paper
• Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2

  2021cites this paper
• Production of Medicines from Engineered Proteins in Plants

  2021cites this paper
• Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?

  2021cites this paper
• A Comprehensive Overview on the Production of Vaccines in Plant-Based Expression Systems and the Scope of Plant Biotechnology to Combat against SARS-CoV-2 Virus Pandemics

  2021cites this paper
• Plant Virology Delivers Diverse Toolsets for Biotechnology

  2020influential citation
• What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?

  2020cites this paper
• Immunotherapy

  2020cites this paper
• Rapid production in maize seedlings of the Ag85B antigen of Mycobacterium avium subsp. paratuberculosis using an Agrobacterium-mediated transient expression system

  2020cites this paper
• Second generation of pepino mosaic virus vectors: improved stability in tomato and a wide range of reporter genes

  2019cites this paper
• Transient Production of Recombinant Pharmaceutical Proteins in Plants: Evolution and Perspectives.

  2019cites this paper
• Transient plant production of Salmonella Typhimurium diagnostic antibodies

  2019cites this paper
• Cryobiotechnology: A Double-Edged Sword for Obligate Plant Pathogens.

  2019cites this paper
• Development of Plant-produced E2 Protein for Use as a Green Vaccine Against Classical Swine Fever Virus

  2018cites this paper
• Plant Virus Expression Vectors: A Powerhouse for Global Health

  2017cites this paper
• Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?

  2017cites this paper
• Recombinant Plant Engineering for Immunotherapeutic Production

  2017cites this paper
• Plant-based vaccines against respiratory diseases: current status and future prospects

  2017cites this paper
• Overexpression and oral immunogenicity of a dengue antigen transiently expressed in Nicotiana benthamiana

  2017cites this paper
• Repression of the DCL2 and DCL4 genes in Nicotiana benthamiana plants for the transient expression of recombinant proteins.

  2017cites this paper
• Corn-based vaccines: current status and prospects

  2017cites this paper
• Transgenesis and Plant Molecular Pharming

  2017cites this paper
• Algevir: An Expression System for Microalgae Based on Viral Vectors

  2017cites this paper
• Algae-Made Antibodies and Immunotoxins

  2016cites this paper
• Advances in Plastid Biology and Its Applications

  2016cites this paper
• Algae-Made Vaccines Targeting Animal Pathogens

  2016cites this paper
• Plant Molecular Pharming

  2016cites this paper
• Plant virus nanoparticles: new applications and new benefits

  2016cites this paper
• Effect of Different Routes of Inoculation on Plant-Derived VP2 Immunogenicity and Ability to Confer Protection Against Infectious Bursal Disease

  2016cites this paper
• Algae-Based Biopharmaceuticals

  2016cites this paper
• The case for plant-made veterinary immunotherapeutics.

  2016cites this paper
• Implications of plant glycans in the development of innovative vaccines

  2016cites this paper
• Expression in plants of two new antigens with implications in Alzheimer’s disease immunotherapy

  2016cites this paper
• Human Papillomavirus Vaccine: State of the Art and Future Perspectives.

  2015cites this paper
• Plastids: The Green Frontiers for Vaccine Production

  2015cites this paper
• From pandemic preparedness to biofuel production: tobacco finds its biotechnology niche in North America.

  2015cites this paper
• Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.

  2015cites this paper
• Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies

  2015influential citation
• The potential of plants for the production and delivery of human papillomavirus vaccines

  2015cites this paper
• Plant-based vaccines for animals and humans: recent advances in technology and clinical trials

  2015cites this paper
• Carrot Cells: A Pioneering Platform for Biopharmaceuticals Production

  2015cites this paper
• Biologia Plantarum Xx (x): Xxx-xxx, 20xx Plant Viruses as Scaffolds for the Presentation of Vaccine Epitopes

  year unknowncites this paper